🔴 Exclusive webinar: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

This Growth Stock Could Be Your Ticket to Riches

Published 2020-11-30, 04:30 p/m
This Growth Stock Could Be Your Ticket to Riches

You’ve probably never heard of this growth stock. Calian Group (TSX:CGY) is headquartered in Ottawa. It currently trades at $55 per share with a market cap of under $538 million. The company began transforming in April 2016 from a stable single-digit growth company to be more growth oriented.

Calian’s results speak for themselves. It has reported profitability for 19 consecutive years — through economic boom and bust. Since April 2016, the TSX stock has delivered total returns of 29% per year. It also offers a dividend that yields 2% at the recent stock price.

Since 2019, it has rallied with only two selloffs. It corrected +25% in the March market crash this year and then ran up to set an all-time high in October. From there, the stock just corrected more than 20%, which could be a good entry point.

Is the stock really on sale? Analysts certainly think so. According to the general consensus, the stock is cheap. Eight analysts have an average 12-month price target of $73.19 on Calian stock, which represents near-term upside potential of approximately 33%.

What does Calian do? Calian provides professional services for a diverse set of clients (private sector, government, and defence). It has four operating segments: Advanced Technologies (35% of revenue), Health (38%), Learning (13%), and Information Technology (13%).

The company grows organically and through acquisitions. It made its first global acquisition in fiscal 2019 and currently has nine subsidiaries. Its latest acquisition is Tallysman, which offers a range of Global Navigation Satellite System, Iridium, and Globalstar antennas.

Recent results and 2021 outlook Last week, Calian reported its fiscal Q4 results. The pandemic had minimal impact on its business. For the year, its revenue rose 26% to $432 million against fiscal 2019.

Organic growth was strong at 21%, driven by its Health and Advanced Technologies segments. Adjusted EBITDA was $36.8 million, up 36%. Adjusted net profit climbed 24% to $23.5 million.

Notably, adjusted earnings per share (EPS) only experienced marginal growth of 0.5% to $2.41 per share due to equity dilution. In fiscal 2020, Calian increased its outstanding shares by about 23% to help fund acquisitions.

It made four acquisitions this year — three of which were in new market verticals. These should serve to expand Calian’s customer base to drive growth.

From fiscal 2017-2019, Calian maintained return on equity of +17%. That has slipped to 12.9% in fiscal 2020. Similarly, its return on assets has fallen meaningfully from 10.4% in fiscal 2017 to 6.2% in fiscal 2020.

The company needs to show it can turn these important metrics around. Management gave fiscal 2021 guidance, which, based on the midpoints of the ranges, imply 8.8% revenue growth, 9.4% adjusted EBITDA growth, and 13.8% adjusted net profit growth. It looks like it’d be a year to digest its recent acquisitions.

Balance sheet As Calian has funded acquisitions largely with equity, its balance sheet remains strong. At the end of fiscal 2020, Calian had cash and cash equivalents of $24.2 million, up 41% year over year. Its debt to equity is 9.8%, down from 11.3% a year ago. Its current ratio was 2.2 times, up from 1.9 times a year ago.

The Foolish takeaway Calian is growing its revenues, adjusted EBITDA, and adjusted earnings meaningfully through organic growth and M&A. However, it’d be more reassuring to see consistent EPS growth as well.

The +20% correction in the stock could be a good opportunity to buy a starter position. If the company executes well and the stock starts ticking upward, interested investors can buy more shares then.

Calian also provides a safe 2% dividend yield, which matches the best five-year GIC rate. Based on Calian’s history of successful execution, it’s likely that the stock will trade much higher from current levels five years from now. So, investors can view the stock as a volatile GIC that guarantees a 2% yield but has higher returns potential.

The post This Growth Stock Could Be Your Ticket to Riches appeared first on The Motley Fool Canada.

Fool contributor Kay Ng has no position in any of the stocks mentioned. The Motley Fool recommends Calian Group Ltd.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2020

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.